Albert Sabin and prove its extraordinary effectiveness and safety. The Sabin vaccine worked in the intestines to block the poliovirus from entering the bloodstream. In the intestines, Sabin had discovered, the poliovirus multiplied and attacked. Thus, the oral vaccine broke the chain of transmission of the virus and allowed for the possibility that polio might one day be eradicated. Between 1955 and 1961, the oral vaccine was tested on at least 100 million people in the USSR, parts of Eastern Europe, Singapore, Mexico, and the Netherlands. The first industrial production and mass use of oral poliovirus vaccine (OPV) from Sabin strains was
Brian Hanley (microbiologist) Brian Hanley (microbiologist) Brian Hanley (born c. 1957) is an American microbiologist and founder of Butterfly Sciences. He is known for using an experimental gene therapy to try to improve health span, and is the first subject in the study. Hanley was 60 years old as of February 2017 and holds a PhD in Microbiology from University of California, Davis. In 2009 he founded Butterfly Sciences in Davis, California to develop a gene therapy to treat HIV AIDS using a combination of GHRH and an intracellular vaccine. He has numerous articles and blog posts, and academic publications in epidemiology, biotechnology,